Predicted biological age reduction (proteomic aging clocks)
Reported model scores on Predicted biological age reduction (proteomic aging clocks), best parseable score first. Each row keeps its verbatim score, test conditions and provenance, and links to the source coverage it was extracted from. Benchmark profile →
| Model | Score | Conditions | Provenance | Measured | Source |
|---|---|---|---|---|---|
| Insilico Medicine AI-designed TNIK inhibitor rentosertib (INS018_055) | up to 6 years on one measure | Phase 2a IPF trial; serum proteomics analyzed by six proteomic aging clocks; reported at 12 weeks | vendor-reported | — | coverage → |
| Insilico Medicine AI-designed TNIK inhibitor rentosertib (INS018_055) | declined by roughly 3 years on average | Phase 2a IPF trial; serum proteomics analyzed by six proteomic aging clocks; reported at 12 weeks | vendor-reported | — | coverage → |
Scores are only comparable within one benchmark under matching conditions — results under different test setups, and scores from other benchmarks, are not directly comparable.